Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
81.16
+0.69 (0.86%)
At close: Jul 30, 2025, 4:00 PM
80.86
-0.30 (-0.37%)
After-hours: Jul 30, 2025, 7:59 PM EDT
Edwards Lifesciences Employees
Edwards Lifesciences had 15,800 employees as of December 31, 2024. The number of employees decreased by 4,000 or -20.20% compared to the previous year.
Employees
15,800
Change (1Y)
-4,000
Growth (1Y)
-20.20%
Revenue / Employee
$359,816
Profits / Employee
$262,506
Market Cap
47.71B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,800 | -4,000 | -20.20% |
Dec 31, 2023 | 19,800 | 2,500 | 14.45% |
Dec 31, 2022 | 17,300 | 1,600 | 10.19% |
Dec 31, 2021 | 15,700 | 800 | 5.37% |
Dec 31, 2020 | 14,900 | 1,000 | 7.19% |
Dec 31, 2019 | 13,900 | 1,100 | 8.59% |
Dec 31, 2018 | 12,800 | 600 | 4.92% |
Dec 31, 2017 | 12,200 | 1,100 | 9.91% |
Dec 31, 2016 | 11,100 | 1,300 | 13.27% |
Dec 31, 2015 | 9,800 | 700 | 7.69% |
Dec 31, 2014 | 9,100 | 500 | 5.81% |
Dec 31, 2013 | 8,600 | 400 | 4.88% |
Dec 31, 2012 | 8,200 | 400 | 5.13% |
Dec 31, 2011 | 7,800 | 800 | 11.43% |
Dec 31, 2010 | 7,000 | 600 | 9.38% |
Dec 31, 2009 | 6,400 | 200 | 3.23% |
Dec 31, 2008 | 6,200 | 600 | 10.71% |
Dec 31, 2007 | 5,600 | 50 | 0.90% |
Dec 31, 2006 | 5,550 | 150 | 2.78% |
Dec 31, 2005 | 5,400 | 200 | 3.85% |
Dec 31, 2004 | 5,200 | 200 | 4.00% |
Dec 31, 2003 | 5,000 | 0 | - |
Dec 31, 2002 | 5,000 | 189 | 3.93% |
Dec 31, 2001 | 4,811 | -289 | -5.67% |
Dec 31, 2000 | 5,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EW News
- 5 days ago - Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance - Benzinga
- 5 days ago - Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results - Benzinga
- 5 days ago - Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Edwards Lifesciences raises annual sales forecast on strong demand for heart devices - Reuters
- 6 days ago - Edwards Lifesciences Reports Second Quarter Results - Business Wire
- 7 days ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 12 days ago - Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025 - Business Wire
- 2 months ago - Edwards Lifesciences: With A Heart Beating Strong And Steady - Seeking Alpha